79761-05-0

Upstream product

• 109345-41-7 N-(tert-butyloxycarbonyl)-S-benzyl-L-cysteinyl-D-valine benzyl ester 
• 3401-33-0 N^Α-Boc-S-benzyl-L-cysteine N-hydroxysuccinimide ester 
• 79761-03-8 N-benzyloxycarbonyl-S-benzyl-L-cysteinyl-D-valine benzyl ester 
• 100-39-0 benzyl bromide 
• 24325-14-2 (2S)-2-[(phenylmethoxy)carbonyl]aminoadipic acid 
• 3257-18-9 benzyloxycarbonyl-S-benzylcysteine 
• 24325-17-5 N-benzyloxycarbonyl-α-benzylester-δ-L-α-aminoadipic acid 
• 123872-88-8 (R)-2-((R)-2-Amino-3-benzylsulfanyl-propionylamino)-3-methyl-butyric acid benzyl ester; hydrochloride 
• 79761-10-7 [(N-benzyloxycarbonyl)-(α-benzyl)-δ-(L-α-aminoadipoyl)]-S-benzyl-L-cysteine 
• 16652-76-9 ammonium tosylate salt of (2R)-valine benzyl ester 

Downstream Products

• 21566-74-5 (L-α-amino-δ-adipyl)-L-cysteinyl-D-valine 
• 69644-78-6 bis[Aad(-Cys-D-Val)] 

Relevant academic research and scientific papers

EFFICIENT ROUTES TO THE ARNSTEINS'S TRIPEPTIDE δ-(L-α-AMINOADIPYL)-L-CYSTEINYL-D-VALINE (LLD ACV) FROM THE OXIDATION PRODUCTS OF L-LYSINE DERIVATIVES

Two efficient syntheses of the linear tripeptide precursor of penam and cephem antibiotics are presented.The routes are characterised by the use of L-lysine derivatives, Z-L-Lys(Z)-OH and H-L-Lys(Z)-OH as starting materials.By the permanganate oxidation t

Synthesis of δ-(L-α-Aminoadipoyl)-L-cysteinyl-D-valine and some Carbon-13 and Nitrogen-15 Labelled Isotopomers

δ-(L-α-Aminoadipoyl)-L-cysteinyl-D-valine (7a), δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine (7b), δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine (7c), and δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine (7d) were prepared by conv